Matches in Nanopublications for { ?s ?p "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_assertion description "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_provenance.
- NP142017.RAYDtlIINi1WAK2c5IqRzsPu4YzqrR7Oeh3Tkl92dqxFY130_assertion description "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP142017.RAYDtlIINi1WAK2c5IqRzsPu4YzqrR7Oeh3Tkl92dqxFY130_provenance.
- NP142471.RAnQoM9QtD4WwAL7apBWzhaerkva2LqceiXABQc-dbw-4130_assertion description "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP142471.RAnQoM9QtD4WwAL7apBWzhaerkva2LqceiXABQc-dbw-4130_provenance.
- assertion description "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP163938.RAUFiCs_B7WtLVcxxwMF0VXVDt2pIZuqHz1Bs4e7eODdk130_assertion description "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163938.RAUFiCs_B7WtLVcxxwMF0VXVDt2pIZuqHz1Bs4e7eODdk130_provenance.
- NP205160.RA39DBezGRXOHfWMSWJWlFhBhZ98Kv2BNQzo-ngqwlfQ8130_assertion description "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP205160.RA39DBezGRXOHfWMSWJWlFhBhZ98Kv2BNQzo-ngqwlfQ8130_provenance.
- NP205612.RAKOYqGNNuWsRFgutMAmnSC9Yxhz_RdLyciTOLpfRXPLs130_assertion description "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP205612.RAKOYqGNNuWsRFgutMAmnSC9Yxhz_RdLyciTOLpfRXPLs130_provenance.
- NP221405.RAx4lLytni8iLYTgHi1d4qZWHrMQgXpb3R5BmZ4Wz4vhQ130_assertion description "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221405.RAx4lLytni8iLYTgHi1d4qZWHrMQgXpb3R5BmZ4Wz4vhQ130_provenance.